BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34629452)

  • 1. Clinical Usefulness of [18F]-Fluoro-2-Deoxy-d-Glucose-Positron Emission Tomography/Computed Tomography for Distinguishing Between Autoimmune Pancreatitis and Pancreatic Cancer.
    Ohtani M; Ofuji K; Akazawa Y; Saito Y; Nosaka T; Ozaki Y; Takahashi K; Naito T; Matsuda H; Hiramatsu K; Nakamoto Y
    Pancreas; 2021 Aug; 50(7):1014-1019. PubMed ID: 34629452
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Zhang J; Jia G; Zuo C; Jia N; Wang H
    BMC Cancer; 2017 Oct; 17(1):695. PubMed ID: 29061130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of whole-body FDG-PET or PET/CT for autoimmune pancreatitis and associated extrapancreatic autoimmune lesions.
    Nakajo M; Jinnouchi S; Fukukura Y; Tanabe H; Tateno R; Nakajo M
    Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):2088-95. PubMed ID: 17713765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDG-PET/CT findings of autoimmune pancreatitis.
    Kamisawa T; Takum K; Anjiki H; Egawa N; Kurata M; Honda G; Tsuruta K
    Hepatogastroenterology; 2010; 57(99-100):447-50. PubMed ID: 20698206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Added Value of
    Chen S; Wang G; Wu L; Chen D; Fang K; Liu W; Xu B; Zhai YQ; Li M
    BMC Gastroenterol; 2024 Jan; 24(1):37. PubMed ID: 38233765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Utility of FDG PET/CT in Patients with Autoimmune Pancreatitis: a Case-Control Study.
    Cheng MF; Guo YL; Yen RF; Chen YC; Ko CL; Tien YW; Liao WC; Liu CJ; Wu YW; Wang HP
    Sci Rep; 2018 Feb; 8(1):3651. PubMed ID: 29483544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is (18)F-fluorodeoxyglucose positron emission tomography meaningful for estimating the efficacy of corticosteroid therapy in patients with autoimmune pancreatitis?
    Shigekawa M; Yamao K; Sawaki A; Hara K; Takagi T; Bhatia V; Nishio M; Tamaki T; El-Amin H; Sayed Zel-A; Mizuno N
    J Hepatobiliary Pancreat Sci; 2010 May; 17(3):269-74. PubMed ID: 19727541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of 18F-FDG PET/CT combined with carbohydrate antigen 19-9 for differentiating pancreatic carcinoma from chronic mass-forming pancreatitis in Chinese elderly.
    Gu X; Liu R
    Clin Interv Aging; 2016; 11():1365-1370. PubMed ID: 27729779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune pancreatitis: whole-body 18F-FDG PET/CT findings.
    Zhang J; Shao C; Wang J; Cheng C; Zuo C; Sun G; Cui B; Dong A; Liu Q; Kong L
    Abdom Imaging; 2013 Jun; 38(3):543-9. PubMed ID: 23223832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of 18F-FDG PET/CT for differentiation of autoimmune pancreatitis with atypical pancreatic imaging findings from pancreatic cancer.
    Lee TY; Kim MH; Park DH; Seo DW; Lee SK; Kim JS; Lee KT
    AJR Am J Roentgenol; 2009 Aug; 193(2):343-8. PubMed ID: 19620430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiomics model of dual-time 2-[
    Liu Z; Li M; Zuo C; Yang Z; Yang X; Ren S; Peng Y; Sun G; Shen J; Cheng C; Yang X
    Eur Radiol; 2021 Sep; 31(9):6983-6991. PubMed ID: 33677645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The differentiation of autoimmune pancreatitis and pancreatic cancer using imaging findings.
    Shin JU; Lee JK; Kim KM; Lee KH; Lee KT; Kim YK; Lim JH; Jang KT
    Hepatogastroenterology; 2013; 60(125):1174-81. PubMed ID: 24298613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of FDG PET/CT derived parameters in prediction of histopathological finding during the surgery in patients with pancreatic adenocarcinoma.
    Myssayev A; Myssayev A; Ideguchi R; Eguchi S; Adachi T; Sumida Y; Tobinaga S; Uetani M; Kudo T
    PLoS One; 2019; 14(1):e0210178. PubMed ID: 30629646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focal autoimmune pancreatitis: radiological characteristics help to distinguish from pancreatic cancer.
    Sun GF; Zuo CJ; Shao CW; Wang JH; Zhang J
    World J Gastroenterol; 2013 Jun; 19(23):3634-41. PubMed ID: 23801866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Differentiation of autoimmune pancreatitis and pancreatic ductal adenocarcinoma based on multi-modality texture features in
    Zhang Y; Cheng C; Liu Z; Pan G; Sun G; Yang X; Zuo C
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2019 Oct; 36(5):755-762. PubMed ID: 31631623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of preoperative fluorodeoxyglucose positron emission tomography/computed tomography in patients with potentially resectable pancreatic cancer.
    Omiya Y; Ichikawa S; Satoh Y; Motosugi U; Nakajima N; Onishi H
    Abdom Radiol (NY); 2018 Dec; 43(12):3381-3389. PubMed ID: 30043215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multidomain fusion model of radiomics and deep learning to discriminate between PDAC and AIP based on
    Wei W; Jia G; Wu Z; Wang T; Wang H; Wei K; Cheng C; Liu Z; Zuo C
    Jpn J Radiol; 2023 Apr; 41(4):417-427. PubMed ID: 36409398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron emission tomography and computed tomography with [
    Pang Y; Zhao L; Shang Q; Meng T; Zhao L; Feng L; Wang S; Guo P; Wu X; Lin Q; Wu H; Huang W; Sun L; Chen H
    Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1322-1337. PubMed ID: 34651226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiomics analysis for the differentiation of autoimmune pancreatitis and pancreatic ductal adenocarcinoma in
    Zhang Y; Cheng C; Liu Z; Wang L; Pan G; Sun G; Chang Y; Zuo C; Yang X
    Med Phys; 2019 Oct; 46(10):4520-4530. PubMed ID: 31348535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.